Maxygen Announces Second Quarter 2009 Earnings Release Date

* Reuters is not responsible for the content in this press release.

Thu Jul 30, 2009 8:00pm EDT 

REDWOOD CITY, Calif.--(Business Wire)--
Maxygen, Inc. (Nasdaq:MAXY), a biotechnology company focused on the development
of improved protein drugs, announced that it will release its second quarter
2009 financial results on Thursday, August 6, 2009 at approximately 4:00 p.m. ET
(1:00 p.m. PT). The earnings release will be available online at www.maxygen.com
and will be filed with the Securities and Exchange Commission. Maxygen will not
host a conference call in connection with its second quarter results. 

About Maxygen

Maxygen is a biopharmaceutical company focused on developing improved versions
of protein drugs through both internal development and external collaborations
and other arrangements. Maxygen uses its proprietary DNA shuffling technology
and extensive protein modification expertise to pursue the creation of
biosuperior proteins. www.maxygen.com



Maxygen, Inc.
Linda Chrisman, 650-298-5351
linda.chrisman@maxygen.com

Copyright Business Wire 2009
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.